Sijmen de Vries, Pharming CEO

Up­dat­ed: FDA ap­proves Pharm­ing drug for ul­tra-rare im­mun­od­e­fi­cien­cy dis­ease

US reg­u­la­tors cleared an ul­tra-rare drug from Pharm­ing Group, by way of No­var­tis, on Fri­day af­ter­noon.

The Dutch biotech said the FDA green­lit le­niolis­ib for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.